Literature DB >> 11683921

Helicobacter pylori CagA: analysis of sequence diversity in relation to phosphorylation motifs and implications for the role of CagA as a virulence factor.

D J Evans1, D G Evans.   

Abstract

CagA is transported into host target cells and subsequently phosphorylated. Clearly this is a mechanism by which Helicobacter pylori could take control of one or more host cell signal transduction pathways. Presumably the end result of this interaction favors survival of H. pylori, irrespective of eventual damage to the host cell. CagA is noted for its amino acid (AA) sequence diversity, both within and outside the variable region of the molecule. The primary purpose of this review is to examine how variation in the type and number of CagA phosphorylation sites might determine the outcome of infection by different strains of H. pylori. The answer to this question could help to explain the widely disparate results obtained when H. pylori CagA status has been compared to type and severity of disease outcome in different populations, that is in different countries. Analysis of all available CagA sequences revealed that CagA contains both tyrosine phosphorylation motifs (TPMs) and cyclic-AMP-dependent phosphorylation motifs (CPMs). There are two potential CPMs near the N-terminus of CagA and at least two in the repeat region; these are not all equally well conserved. We also defined a 48-residue AA sequence, which includes the N-terminal TPM at tyrosine (Y)-122, which distinguishes between Eastern (Hong Kong-Taiwan-Japan-Thailand) H. pylori isolates and those from the West (Europe-Africa-the Americas-Australia). All 28 of the Eastern type CagA proteins have a functional N-terminal TPM whereas 11 of 47 (23.4%) of the Western type contain an inactive motif, with threonine (T) replacing the critical aspartic acid (D) residue. Only 13 of 24 (54%) known CagA sequences have an active TPM in the repeat region and only one has two TPMs in this region. The potential TPM near the C-terminus of CagA is not likely to be important since only 3 of 24 (12.5%) sequences were found to be intact. Protein database searches revealed that the AA sequence immediately following the TPM at Y-122 in CagA is homologous with a pair of PDZ domains which are common in signal transducing proteins, particularly tyrosine phosphatases. This provides a theoretical link between CagA and many of the observed responses of host cells to H. pylori. In summary, not all CagA proteins are equal in their potential for initiating host cell responses via signal transduction pathways. The degree of functional diversity of this protein depends upon which phosphorylation motifs are critical to the biological activity of CagA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683921     DOI: 10.1046/j.1523-5378.2001.00028.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  10 in total

1.  Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection.

Authors:  Patrice A Marchildon; Toshiro Sugiyama; Yoshihiro Fukuda; Jeffrey S Peacock; Masahiro Asaka; Takashi Shimoyama; David Y Graham; Yoshihiro Fukada
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Fusion expression of Helicobacter pylori neutrophil-activating protein in E.coli.

Authors:  Qiao-Zhen Kang; Guang-Cai Duan; Qing-Tang Fan; Yuan-Lin Xi
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

3.  Helicobacter pylori CagA protein polymorphisms and their lack of association with pathogenesis.

Authors:  Nicole Acosta; Andrés Quiroga; Pilar Delgado; María-Mercedes Bravo; Carlos Jaramillo
Journal:  World J Gastroenterol       Date:  2010-08-21       Impact factor: 5.742

4.  High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain.

Authors:  Sonia Agudo; Guillermo Pérez-Pérez; Teresa Alarcón; Manuel López-Brea
Journal:  J Clin Microbiol       Date:  2010-07-28       Impact factor: 5.948

5.  Identification of cagA tyrosine phosphorylation DNA motifs in Helicobacter pylori isolates from peptic ulcer patients by novel PCR-restriction fragment length polymorphism and real-time fluorescence PCR assays.

Authors:  Robert J Owen; Sally I Sharp; Stephanie A Chisholm; Sjoerd Rijpkema
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

6.  Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais.

Authors:  Sirikan Yamada; Takeshi Matsuhisa; Luksana Makonkawkeyoon; Suparp Chaidatch; Shunji Kato; Norio Matsukura
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

7.  Helicobacter pylori impedes acid-induced tightening of gastric epithelial junctions.

Authors:  Elizabeth A Marcus; Olga Vagin; Elmira Tokhtaeva; George Sachs; David R Scott
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-08-29       Impact factor: 4.052

8.  Microevolution of Helicobacter pylori type IV secretion systems in an ulcer disease patient over a ten-year period.

Authors:  Ayesha Alvi; S Manjulata Devi; Irshad Ahmed; M Abid Hussain; Mohammed Rizwan; Hérve Lamouliatte; Francis Mégraud; Niyaz Ahmed
Journal:  J Clin Microbiol       Date:  2007-10-17       Impact factor: 5.948

9.  Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer.

Authors:  Steffen Backert; Tobias Schwarz; Stephan Miehlke; Christian Kirsch; Christian Sommer; Terry Kwok; Markus Gerhard; Ulf B Goebel; Norbert Lehn; Wolfgang Koenig; Thomas F Meyer
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Outcome of immunosuppressive therapy with Helicobacter pylori eradication therapy in patients with chronic idiopathic thrombocytopenic purpura.

Authors:  Moo-Kon Song; Joo-Seop Chung; Ho-Jin Shin; Young-Jin Choi; Goon-Jae Cho
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.